As drug companies face requirements to report all spending on physician-related activity, relationships between thought leaders Read More >>

Research and Markets (http://www.researchandmarkets.com/research/37128c/eli_lilly_and_comp) has announced the addition of the "Eli Lilly and Compa Read More >>

Eli Lilly & Co. (LLY)

Expected next earnings release:

Announcement date: 4/19/2010 - Before Market

Earnings Quarter: Q1

Announc
          
            Read More
            >>
          
        

Eli Lilly & Co. (LLY)

Expected next earnings release:

Announcement date: 4/19/2010 - Before Market

Earnings Quarter: Q1

Announc
          
            Read More
            >>
          
        

Attorney General Jim Hood said Thursday he hopes the Legislature will use settleme Read More >>

SUMMARY: The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of an original new animal drug application (NADA) Read More >>

Aspen Pharmacare, a South African generic pharmaceutical company, has entered into a $1 million agreement with Eli Lilly, a US-based pharmaceutical company, Read More >>

Subscribers to galtstock.com "Long-Term Portfolio" service (membership) invest in solid long-term holdings. Our portfolio is actively managed Read More >>

Lilly USA recently was recognized by the eHealthcare Leadership Awards and the Web Marketing Association for its Health Education Answers prog Read More >>

As the need for health care assistance mounts after the recent catastrophic earthquake in Haiti, America's pharmaceutical research and biotechno Read More >>

Starpharma Holdings, a developer of dendrimer technology, has signed a new agreement with Eli Lilly and Company under which Starpharma's dendrimer drug deli Read More >>

Genzyme Corporation (NASDAQ: GENZ) announced today that Scott Canute, the former manufacturing head at Eli Lilly & Company and Read More >>

In a new study, 60 mg of Cymbalta(R) (duloxetine HCl) taken once daily significantly reduced chronic low back pain, as measured by the Brief P Read More >>

MODA Technology Partners, a global software company that automates environmental monitoring (EM), utility and product testing for the Pharmaceutica Read More >>

Eli Lilly and Company has entered into an agreement with Starpharma Holdings Limited, under which Lilly will apply Starpharma's dend Read More >>

Zelos Therapeutics has initiated dosing in a seven day clinical study of a nasal spray formulation of ZT-034, or teriparatide, which is being developed in c Read More >>

Eli Lilly and Company has reported a net income of $915.4 million, or $0.83 per share, for the fourth quarter of 2009, compared to a net loss of $3.62 billi Read More >>

TSX symbol: SBS

SemBioSys Genetics Inc. (TSX:SBS) today announced that its Biosimilar Insulin program was featured last night on CTV Na Read More >>

Starpharma Holdings Limited (ASX: SPL, OTCQX: SPHRY) today announced the signing of a new agreement with Eli Lilly and Company (NYSE: Read More >>

Drug manufacturer Eli Lilly amp& Co. will pay $18.5 million to shut down Missis Read More >>

Eli Lilly & Co. (LLY)

Expected next earnings release:

Announcement date: 4/20/2010 - Before Market

Earnings Quarter: Q1

Announc
          
            Read More
            >>
          
        

Zacks.com releases the latest Industry Outlook. Today, Zacks Equity Research discusses the Pharma & Biotech Industry, including GlaxoSmithKline Read More >>

As the need for health care assistance mounts after the recent catastrophic earthquake in Haiti, America's pharmaceutical research and biotechno Read More >>

Eli Lilly & Co. (LLY)

Expected next earnings release:

Announcement date: 1/28/2010 - Before Market

Earnings Quarter: Q4

Announc
          
            Read More
            >>
          
        

Drug manufacturer Eli Lilly & Co. will pay $18.5 million to shut down Mississip Read More >>

Zelos Therapeutics, Inc. has initiated dosing in a seven day clinical study of a nasal spray formulation of ZT-034 (teriparatide) tha Read More >>

Eli Lilly and Company (NYSE: LLY) said it continues to expect 2010 earnings of $4.65 to $4.85 per share. The current consensus earni Read More >>

Double-digit revenue growth in Q4 driven by higher volume

Weaker dollar results in decreased Q4 gross margin

Company delivers Q Read More >>

(Comment on this article at http://www.financialwire.net/2010/01/28/conference-calls-today-9-a-m-est-7/)

January 28, 2010 (FinancialWire) (Invest Read More >>

Eli Lilly & Co. (LLY)

Expected next earnings release:

Announcement date: 1/28/2010 - Before Market

Earnings Quarter: Q4

Announc
          
            Read More
            >>
          
        

Alize Pharma SAS, a France-based biopharmaceutical company, has entered into a research collaboration and license option agreement w Read More >>

Alize Pharma SAS, a France-based biopharmaceutical company, has entered into a research collaboration and license option agreement w Read More >>

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that Amylin/Eli L Read More >>

Gastrointestinal Cancers Symposium:

  --  Promising pancreatic cancer-specific 
          
            Read More
            >>
          
        

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that a fibromyalg Read More >>

Shionogi & Co has received the marketing and manufacturing approval of a serotonin noradrenalin reuptake inhibitor Cymbalta capsules 20mg and 30mg for d Read More >>

Responding to a continuing push from lawmakers to reveal how much the pharmaceutical industry is influencing A Read More >>

BioNJ, New Jersey's trade association for the biotechnology community, announced today that the third annual Dr. Sol J. Barer Award for Vision Read More >>

Seven Summits Research issues PriceWatch Alerts for BRK.B, PM, AFL, LLY, and DHI.

Seven Summits Strategic Investments' PriceWatch Alerts ar Read More >>

Albemarle Corporation has entered into an agreement with Elanco Animal Health, under which Elanco will market its portfolio of food- Read More >>

Cardica, Inc. (Nasdaq: CRDC) today announced that Brian E. Farley has agreed to be a strategic, financial and business consultant to t Read More >>

Albemarle Corporation (NYSE: ALB), global leader in providing innovative specialty chemicals to the food service industry, announced today Read More >>

As the need for health care assistance mounts in Haiti after last week's catastrophic earthquake, America's pharmaceutical research and biotechn Read More >>

T-Ray Science, Inc. (TSX VENTURE:THZ) ("T-Ray" or the "Company") announced today that Tom Walker is joining T-Ray as the Company Read More >>

Donations of medicines and money will help with relief operations Las Vegas CRWENews.com is pleased to announce a stock highlight on Eli Lilly and Company Read More >>

BioNJ, New Jersey's trade association for the biotechnology community, will hold its 17th Annual Dinner Meeting, Awards Program and Ne Read More >>

In the keynote address at a Town Hall Los Angeles luncheon event today, John C. Lechleiter, Ph.D., chairman and CEO of Eli Lilly and Company, s Read More >>